Developments ANSM grants clearance for Anteris trial of transcatheter heart valve Anteris Technologies Global (NASDAQ: AVR; ASX: AVR) has received full regulatory clearance from the French National Agency for Medicines and Health Products Safety (ANSM) enabling patient recruitment to begin in France... June 8, 2026